Clinical Trial Update: First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating first-line chemotherapy followed by toripalimab plus anlotinib for maintenance in extensive-stage small cell lung cancer (ES-SCL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Taizhou Hospital | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN